ArticleAdvances in therapy2022

Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World.

Gentry King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.